Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


11.06.2018

1 Am J Psychiatry
1 Br J Psychiatry
1 Compr Psychiatry
1 J Clin Psychiatry
1 Neuropsychology
6 Psychiatry Res
1 Psychol Med
6 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Psychiatry

  1. EL-MALLAKH RS, Furdek C
    Cycloid Psychosis.
    Am J Psychiatry. 2018;175:502-505.
    PubMed     Text format    


    Br J Psychiatry

  2. FOND G, Boyer L, Berna F, Godin O, et al
    Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.
    Br J Psychiatry. 2018 Jun 6:1-7. doi: 10.1192/bjp.2018.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  3. AVEROUS P, Charbonnier E, Lagouanelle-Simeoni MC, Prosperi A, et al
    Illness perceptions and adherence in bipolar disorder: An exploratory study.
    Compr Psychiatry. 2018;80:109-115.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  4. KEEFE RSE, Harvey PD, Khan A, Saoud JB, et al
    Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    Neuropsychology

  5. BECHI M, Bosia M, Agostoni G, Spangaro M, et al
    Can patients with schizophrenia have good mentalizing skills? Disentangling heterogeneity of theory of mind.
    Neuropsychology. 2018 Jun 7. pii: 2018-25396-001. doi: 10.1037/neu0000456.
    PubMed     Text format     Abstract available


    Psychiatry Res

  6. JAGANNATH V, Gerstenberg M, Walitza S, Franscini M, et al
    Neuregulin 1 (NRG1) gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis.
    Psychiatry Res. 2018;266:143-146.
    PubMed     Text format     Abstract available

  7. DE NIJS J, Meijer JH, de Haan L, Meijer CJ, et al
    Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls.
    Psychiatry Res. 2018;266:147-151.
    PubMed     Text format     Abstract available

  8. YANG Z, Li L, Li M
    De novo mutations as causes of schizophrenia.
    Psychiatry Res. 2018 May 18. pii: S0165-1781(18)30610.
    PubMed     Text format    

  9. HASEGAWA T, Hashimoto T, Kanahara N, Yamanaka H, et al
    Identifying improvable employment-related factors in schizophrenia patients.
    Psychiatry Res. 2018;266:199-205.
    PubMed     Text format     Abstract available

  10. SAVITZ A, Melkote R, Riley R, Pobre MA, et al
    Use of antipsychotic blood levels in clinician decision making: A cross-over study using clinical vignettes of patients with schizophrenia.
    Psychiatry Res. 2018;267:25-29.
    PubMed     Text format     Abstract available

  11. CHUNG KH, Chen PH, Kuo CJ, Tsai SY, et al
    Risk factors for early circulatory mortality in patients with schizophrenia.
    Psychiatry Res. 2018;267:7-11.
    PubMed     Text format     Abstract available


    Psychol Med

  12. HARTMANN JA, Nelson B, Ratheesh A, Treen D, et al
    At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging.
    Psychol Med. 2018 Jun 4:1-13. doi: 10.1017/S0033291718001435.
    PubMed     Text format     Abstract available


    Schizophr Res

  13. LEE J, Yoon YB, Wijtenburg SA, Rowland LM, et al
    Lower glutamate level in temporo-parietal junction may predict a better response to tDCS in schizophrenia.
    Schizophr Res. 2018 May 30. pii: S0920-9964(18)30297.
    PubMed     Text format    

  14. MORADI H, Harvey PD, Helldin L
    Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?
    Schizophr Res. 2018 May 30. pii: S0920-9964(18)30300.
    PubMed     Text format     Abstract available

  15. YUAN X, Zhang P, Wang Y, Liu Y, et al
    Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia.
    Schizophr Res. 2018 May 30. pii: S0920-9964(18)30274.
    PubMed     Text format     Abstract available

  16. SETIEN-SUERO E, Martinez-Garcia O, de la Foz VO, Vazquez-Bourgon J, et al
    Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up.
    Schizophr Res. 2018 May 31. pii: S0920-9964(18)30301.
    PubMed     Text format     Abstract available

  17. ANDERSEN E, Holmen TL, Egeland J, Martinsen EW, et al
    Physical activity pattern and cardiorespiratory fitness in individuals with schizophrenia compared with a population-based sample.
    Schizophr Res. 2018 May 31. pii: S0920-9964(18)30303.
    PubMed     Text format     Abstract available

  18. SAHOO S, Grover S, Nehra R
    Comparison of neurocognitive domains in patients with schizophrenia with and without co-morbid obsessive compulsive disorder.
    Schizophr Res. 2018 May 29. pii: S0920-9964(18)30286.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: